Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

3.

Nasal therapeutic HPV vaccine could prevent cervical cancer

4.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

5.

Report suggests a big improvement in lung cancer survival


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot